NCT00606502 2021-03-05Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based TreatmentSpectrum Pharmaceuticals, IncPhase 2 Completed201 enrolled 12 charts
NCT00321893 2016-01-25Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung CancerNational Cancer Institute (NCI)Phase 2 Completed225 enrolled 10 charts